TOMI Environmental Solutions announced participation at AALAS meeting to showcase its SteraMist SIS platform for animal research decontamination.
Quiver AI Summary
TOMI Environmental Solutions, Inc. announced its participation in the AALAS 76th National Meeting from November 9-13, 2025, in Long Beach, California. This event serves as a significant platform for TOMI to foster connections with industry leaders and potential partners, particularly to promote its SteraMist Integrated System (SIS) technology for decontamination in animal research environments. The company's executive team will engage in strategic discussions with key distributors like ARES Scientific to enhance its distribution channels. TOMI's COO, Elissa J. Shane, emphasized the importance of the conference for showcasing their technology and driving advancements in research safety and efficiency. The meeting is expected to accelerate TOMI's growth and highlights the company’s commitment to delivering innovative decontamination solutions worldwide.
Potential Positives
- TOMI is participating in the AALAS 76th National Meeting, which provides a significant opportunity for networking with industry leaders and expanding its market presence.
- The engagement at AALAS allows TOMI to showcase its SteraMist Integrated System (SIS) platform, reinforcing its position as a frontrunner in decontamination solutions for animal research environments.
- The press release highlights the strategic meetings with key distributors like ARES Scientific, aimed at amplifying distribution channels and increasing adoption of TOMI's innovative technology.
- The presence of a high-level executive team at the event signals TOMI's commitment to growth and innovation in the industry, enhancing its credibility and customer engagement.
Potential Negatives
- This press release includes a strong emphasis on forward-looking statements, indicating a reliance on uncertain future performance, which may raise concerns among investors regarding the company's stability and ability to meet growth expectations.
- The mention of reliance on a single or a few products for a majority of revenues suggests potential vulnerability to market fluctuations or changes in demand, posing risks to financial performance.
- The caution regarding unknown or unpredictable factors that could affect actual results may be seen as a red flag for investors, indicating that the company could face challenges that are not currently anticipated.
FAQ
What event is TOMI Environmental Solutions attending?
TOMI is participating in the AALAS 76th National Meeting in Long Beach, California, from November 9-13, 2025.
What technology will TOMI showcase at AALAS?
TOMI will showcase its SteraMist Integrated System (SIS) platform, which uses innovative ionized Hydrogen Peroxide (iHP) technology.
Who is leading TOMI's team at the event?
The team is led by TOMI's Chief Operating Officer and includes key executives in product compliance, sales, and revenue.
Why is AALAS significant for TOMI?
AALAS offers TOMI an opportunity for networking, lead generation, and strengthening partnerships in the animal research sector.
What does TOMI aim to achieve from AALAS 2025?
TOMI aims to expand distribution channels and drive adoption of their decontamination solutions through collaboration and innovation.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$TOMZ Hedge Fund Activity
We have seen 6 institutional investors add shares of $TOMZ stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SCARBOROUGH ADVISORS, LLC removed 79,413 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $84,590
- VANGUARD GROUP INC added 46,952 shares (+8.5%) to their portfolio in Q3 2025, for an estimated $47,421
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 13,767 shares (+24.1%) to their portfolio in Q2 2025, for an estimated $14,664
- DYNAMIC ADVISOR SOLUTIONS LLC removed 11,305 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $11,418
- UBS GROUP AG removed 3,287 shares (-30.6%) from their portfolio in Q2 2025, for an estimated $3,501
- RENAISSANCE TECHNOLOGIES LLC removed 2,193 shares (-16.5%) from their portfolio in Q2 2025, for an estimated $2,335
- RAYMOND JAMES FINANCIAL INC added 2,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,130
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
FREDERICK, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced its participation and speaking engagement at the American Association for Laboratory Animal Science (AALAS) 76th National Meeting, being held November 9-13, 2025, in Long Beach, California.
This premier event represents an opportunity for TOMI to connect with industry leaders, maintain strategic partnerships, and expand the reach of its groundbreaking SteraMist Integrated System (SIS) platform, positioning the company at the forefront of evolving decontamination solutions in animal research environments.
AALAS has long been a powerhouse for lead generation at TOMI, drawing thousands of professionals from research institutions and laboratories. This year's meeting offers a platform to accelerate growth through high-impact networking and collaborations. TOMI's team will engage in strategic meetings with key distributors, including ARES Scientific , to amplify distribution channels and drive further adoption of its innovative ionized Hydrogen Peroxide (iHP) technology.
Leading TOMI's presence at the event will be a powerhouse executive team, including the Chief Operating Officer, Director of Product Compliance and Manufacturing, Director of Sales, and Chief Revenue Officer. This dynamic lineup reflects TOMI's commitment to innovation and customer-centric growth.
"We're excited to showcase how our SteraMist SIS platform can integrate seamlessly with partners and customers, driving unprecedented advancements in animal research safety and efficiency,” stated Elissa J. (E.J.) Shane, TOMI’s COO. “Leveraging the AALAS platform propels our mission of delivering superior decontamination solutions worldwide. With a focus on innovation and collaboration, we are set to capitalize on the vast opportunities emerging in the animal research sector, paving the way for breakthroughs that benefit researchers, institutions, and the broader scientific community,”
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.
For additional information, please visit http://www.steramist.com or contact us at [email protected]
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products to serve life science sectors. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
[email protected]